Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy

Background: Gonadotropin-releasing hormone agonists (GnRHa), used in the treatment of prostate cancer (PC) and for reproductive purposes in women, have been implicated as the cause of pituitary apoplexy (PA), a potentially life-threatening condition. The pathophysiology of PA after GnRHa has not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiaoling, Guarda, Francisco J, Shiraliyeva, Naila, Haines, Melanie S, Saylor, Philip J, Nachtigall, Lisa B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090722/
http://dx.doi.org/10.1210/jendso/bvab048.1281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090722/
http://dx.doi.org/10.1210/jendso/bvab048.1281

Ejemplares similares